Patent Issued for Treatment of obstructive sleep apnea (OSA) (USPTO 11839407).

A patent has been issued to Medtronic Xomed Inc. for a treatment of obstructive sleep apnea (OSA). The patent describes an implantable medical device system and methods for therapy for OSA. The system involves electrically stimulating the hypoglossal nerves and/or motor points in the tongue to contract and move the tongue forward, thereby opening the airway. The patent also discusses techniques for lead structures and lead placement to provide effective therapy. This information may be useful for individuals researching OSA treatment options. [Extracted from the article]